Genmab — Maj 2016
-
Her er risikoen i Genmab: http://play.borsen.dk/social/57322828725ed7540a0d4433
-
Efter min ydmyge mening.
-
Deutsche Bank maintain buy on Genmab. Increase target price from 1000 to 1107. Deutsche lower WACC from 9% to 8,5% and increase Darzalex peak sale estimate from $5.5bn to $6.5bn.
-
ja i 2023
-
Iøvrigt interessant at læse, at Deutsche Bank regner med prisfald på 10%. Så en hvis Hillary Clinton effect har de allerede indregnet (Hillary nævnes dog ikke i analysen)
-
Sad lige og læste CC-transscriptet. Hovsa: That could actually end up in next year. If not that will be in 2018 that we hope for '17 for at least one of the frontline studies to read out in the interim. Dvs Winkel udelukker ikke at et af 1. linje-studierne
kan få interim-readout allerede i 2017. -
Jeg så det også Bulder
Det er en rigtig god nyhed. Så der er mulighed for frontline salg allerede i 2018! -
Florian køber op.. http://play.borsen.dk/share/573228c2725ed7540a0d446d
-
Jeg har plads til flere spørgsmål på vores Q&A. Skyd bare løs.
-
Anonyme fik da lige trykket på købsknappen.
-
Masser af Genmabsnak på Mio-klubben i dag. Ca. 15,30 inde i udsendelsen. http://www.radio24syv.dk/programmer/millionaerklubben/13500955/millionaerklubben-11-05-2016/
-
ATH luk på 1000
-
Dejlig rundt ral :-))
-
Tal
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind